 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - G1 Therapeutics Inc. (GTHX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-12-26 Purchase | 2018-12-27 4:59 pm | G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel | 1,000 | $18.25 | $18,250 | 3,000 (Direct) | View |
| 2018-12-26 Purchase | 2018-12-27 4:59 pm | G1 Therapeutics Inc. | GTHX | Schwalm Cynthia Director | 1,420 | $18.45 | $26,196 | 1,500 (Direct) | View |
| 2018-12-17 Sale | 2018-12-17 4:27 pm | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 3,776 | $30 | $113,280 | 14,700 (Direct) | View |
| 2018-12-10 Purchase | 2018-12-11 4:08 pm | G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel | 1,000 | $32.51 | $32,508 | 2,000 (Direct) | View |
| 2018-12-10 Purchase | 2018-12-11 4:08 pm | G1 Therapeutics Inc. | GTHX | DEMAREE JOHN Chief Commercial Officer | 1,000 | $33.15 | $33,151 | 5,250 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,000 | $3.72 | 3,333 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,000 | $3.72 | 3,333 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 2,500 | $0.39 | 82,944 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A 2024-07-11 | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 2,500 | $0.39 | 82,944 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 3,000 | $0.39 | 371,286 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 3,000 | $0.39 | 371,286 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-13 4:02 pm | N/A 2030-03-12 | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. Director | 40,000 | $12 | 40,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:15 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 60,000 | $21.08 | 60,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:15 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | DEMAREE JOHN Chief Commercial Officer | 30,000 | $21.08 | 30,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:15 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel | 60,000 | $21.08 | 60,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:14 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L COO | 60,000 | $21.08 | 60,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:14 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 60,000 | $21.08 | 60,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:14 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 80,000 | $21.08 | 80,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:14 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 220,000 | $21.08 | 220,000 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:59 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 6,000 | $0.39 | 374,286 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:59 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 6,000 | $0.39 | 374,286 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:58 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 1,000 | $3.72 | 5,333 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:58 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 1,000 | $3.72 | 5,333 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:58 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 5,000 | $0.39 | 85,444 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:58 pm | N/A 2024-07-11 | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 5,000 | $0.39 | 85,444 (Direct) | View |
| 2019-07-29 Option Award | 2019-07-30 4:29 pm | N/A 2029-07-29 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 300,000 | $25.72 | 300,000 (Direct) | View |
| 2019-07-18 Exercise | 2019-07-19 9:58 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,000 | $3.72 | 6,333 (Direct) | View |
| 2019-07-18 Exercise | 2019-07-19 9:58 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,000 | $3.72 | 6,333 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-14 4:38 pm | N/A 2029-06-12 | G1 Therapeutics Inc. | GTHX | ESHELMAN FREDRIC N Director | 20,000 | $18.47 | 20,000 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-14 4:36 pm | N/A 2029-06-12 | G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director | 20,000 | $18.47 | 20,000 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-14 4:35 pm | N/A 2029-06-12 | G1 Therapeutics Inc. | GTHX | Deese Willie A Director | 20,000 | $18.47 | 20,000 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-14 4:33 pm | N/A 2029-06-12 | G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director | 20,000 | $18.47 | 100,000 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-14 4:33 pm | N/A 2029-06-12 | G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director | 100,000 | $18.47 | 100,000 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-14 4:32 pm | N/A 2029-06-12 | G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director | 20,000 | $18.47 | 20,000 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-14 4:31 pm | N/A 2029-06-12 | G1 Therapeutics Inc. | GTHX | Schwalm Cynthia Director | 20,000 | $18.47 | 20,000 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-14 4:30 pm | N/A 2029-06-12 | G1 Therapeutics Inc. | GTHX | WITTY ANDREW Director | 20,000 | $18.47 | 20,000 (Direct) | View |
| 2019-05-08 Option Award | 2019-05-10 4:26 pm | N/A 2029-05-08 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 50,000 | $20.91 | 50,000 (Direct) | View |
| 2019-01-28 Exercise | 2019-01-28 9:10 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 7,000 | $0.39 | 90,444 (Direct) | View |
| 2019-01-28 Exercise | 2019-01-28 9:10 pm | N/A 2024-07-11 | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 7,000 | $0.39 | 90,444 (Direct) | View |
| 2019-01-17 Exercise | 2019-01-17 5:52 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP | 2,000 | $3.72 | 8,333 (Direct) | View |
| 2019-01-17 Exercise | 2019-01-17 5:52 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP | 2,000 | $3.72 | 8,333 (Direct) | View |
| 2019-01-17 Exercise | 2019-01-17 5:52 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 9,000 | $0.39 | 380,286 (Direct) | View |
| 2019-01-17 Exercise | 2019-01-17 5:52 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 9,000 | $0.39 | 380,286 (Direct) | View |
| 2019-01-02 Exercise | 2019-01-02 5:46 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer | 39,485 | $0.3 | 0 (Direct) | View |
| 2019-01-02 Exercise | 2019-01-02 5:46 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer | 40,333 | $0.39 | 0 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 5:46 pm | N/A 2029-01-02 | G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer | 15,000 | $19.56 | 0 (Direct) | View |
| 2019-01-02 Exercise | 2019-01-02 5:46 pm | N/A 2024-01-21 | G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer | 13,333 | $0.39 | 0 (Direct) | View |
| 2019-01-02 Exercise | 2019-01-02 5:46 pm | N/A 2024-07-11 | G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer | 27,000 | $0.39 | 0 (Direct) | View |
| 2019-01-02 Exercise | 2019-01-02 5:46 pm | N/A 2022-11-09 | G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer | 15,816 | $0.3 | 0 (Direct) | View |
| 2019-01-02 Exercise | 2019-01-02 5:46 pm | N/A 2023-01-09 | G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer | 10,336 | $0.3 | 0 (Direct) | View |
| 2019-01-02 Exercise | 2019-01-02 5:46 pm | N/A 2023-04-16 | G1 Therapeutics Inc. | GTHX | Strum Jay Chief Scientific Officer | 13,333 | $0.3 | 0 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 5:32 pm | N/A 2029-01-02 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. VP | 20,000 | $19.56 | 20,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 5:29 pm | N/A 2029-01-02 | G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel | 60,000 | $19.56 | 60,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 5:29 pm | N/A 2029-01-02 | G1 Therapeutics Inc. | GTHX | PHILLIPS BARCLAY A CFO | 60,000 | $19.56 | 60,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 5:29 pm | N/A 2029-01-02 | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L COO | 60,000 | $19.56 | 60,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 5:29 pm | N/A 2029-01-02 | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 60,000 | $19.56 | 60,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 5:28 pm | N/A 2029-01-02 | G1 Therapeutics Inc. | GTHX | DEMAREE JOHN Chief Commercial Officer | 60,000 | $19.56 | 60,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 5:28 pm | N/A 2029-01-02 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 225,000 | $19.56 | 225,000 (Direct) | View |
| 2018-12-17 Exercise | 2018-12-17 4:27 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 3,776 | $4.17 | 14,700 (Direct) | View |
| 2018-12-17 Exercise | 2018-12-17 4:27 pm | N/A 2026-05-10 | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 3,776 | $4.17 | 14,700 (Direct) | View |